e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Asthma management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Monitoring of steroid-induced side-effects in a severe asthma service
G. Jones (Ellesmere Port, United Kingdom)
Source:
International Congress 2017 – Asthma management
Session:
Asthma management
Session type:
Thematic Poster
Number:
3969
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Jones (Ellesmere Port, United Kingdom). Monitoring of steroid-induced side-effects in a severe asthma service. 3969
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Combination asthma medication and healthcare use in severe or difficult-to-treat asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 131s
Year: 2004
Management of difficult-to-treat severe asthma
Source: Eur Respir Mon 2011; 51: 282-296
Year: 2011
Assessing severe asthma
Source: Eur Respir J 2016; 48: 611-613
Year: 2016
The use of omalizumab in the management of severe chronic paediatric asthma
Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma
Year: 2008
Use of parenteral long-term bronchodilators in the management of severe and life-threatening asthma
Source: Annual Congress 2003 - Recognition, management and assessment of asthma including severe asthma
Year: 2003
Cost implications for the introduction of omalizumab in to the management of severe chronic asthma in children
Source: Eur Respir J 2006; 28: Suppl. 50, 481s
Year: 2006
The ’real-life’ long-term efficacy of omalizumab in severe persistent IgE-mediated allergic asthma in Malta
Source: International Congress 2016 – Asthma management
Year: 2016
Predictors of severe asthma exacerbations, poor asthma control and beta-agonist overuse in adult asthma
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
Oral corticosteroids-related comorbidities in severe asthma
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021
Management of severe and difficult-to-treat asthma
Source: Annual Congress 2013 –Severe asthma: moving from phenotyping to endotyping
Year: 2013
Evolution from mild to severe asthma; the severe asthma clinic perspective
Source: International Congress 2019 – Clinical implications of asthma management
Year: 2019
Extent of uncontrolled disease and associated medical costs in severe asthma in the Netherlands
Source: Annual Congress 2007 - Epidemiology of asthma
Year: 2007
The management of mild asthma
Source: Eur Respir J, 57 (4) 2003051; 10.1183/13993003.03051-2020
Year: 2021
Acute severe asthma: evidence-based management of asthma exacerbations
Source: Annual Congress 2008 - PG4 - Paediatric respiratory medicine: wheezing children: asthma and beyond
Year: 2008
Use of beta-agonist therapy prior to hospital attendance for severe exacerbations of asthma
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
Evaluating the efficacy of omalizumab in severe persistent asthma patients
Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Year: 2017
What matters to people with severe asthma? Exploring add-on asthma medication and outcomes of importance
Source: ERJ Open Res, 7 (1) 00497-2020; 10.1183/23120541.00497-2020
Year: 2021
Severe allergic asthma in routine outpatient care
Source: Annual Congress 2009 - Epidemiology of asthma
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept